Clinical Trial Update: Study to Assess the Efficacy of an Extended Injection Interval Schedule of Lanreotide Autogel in Acromegalic Subjects [Phase 4]

View source ↗

Summary

A Phase 4 study assessing the efficacy of an extended injection interval schedule of lanreotide Autogel in people with acromegaly, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly

Drugs mentioned

• Lanreotide Autogel (lanreotide)

Snippet

Sponsor: Ipsen | Conditions: Acromegaly | Phase 4 | Status: COMPLETED | Results posted: 2015-12-14